Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study

1

Multiparametric MRI is the gold standard for prostate cancer diagnosis, guiding the need for systematic and targeted biopsies.
2

Perilesional biopsies may enhance detection rates of clinically significant prostate cancer while potentially reducing unnecessary systematic biopsies.
3

The study aimed to evaluate whether adding perilesional biopsies could replace systematic biopsies without compromising cancer detection.
4

Participants included men with specific PSA levels and prostate volumes, ensuring a focused study population for the biopsy evaluation.
5

The study was conducted in accordance with ethical guidelines, emphasizing the importance of informed consent and safety protocols.

World Journal Of Urology

by Gregor Duwe, Melanie Schmitteckert, Maximilian Haack, Peter Sparwasser, Robert Dotzauer, Anita Thomas, Igor Tsaur, Maximilian Peter Brandt, Martin Kurosch, Rene Mager, Axel Haferkamp, Katharina Boehm, Thomas Höfner
May 6, 2024

1